KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Amgen (AMGN) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $7.0 billion.

  • Amgen's Operating Expenses rose 890.64% to $7.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $27.3 billion, marking a year-over-year increase of 373.92%. This contributed to the annual value of $26.2 billion for FY2024, which is 2894.1% up from last year.
  • Latest data reveals that Amgen reported Operating Expenses of $7.0 billion as of Q3 2025, which was up 890.64% from $6.5 billion recorded in Q2 2025.
  • Over the past 5 years, Amgen's Operating Expenses peaked at $7.0 billion during Q3 2025, and registered a low of $3.7 billion during Q1 2022.
  • Moreover, its 5-year median value for Operating Expenses was $4.9 billion (2023), whereas its average is $5.4 billion.
  • As far as peak fluctuations go, Amgen's Operating Expenses crashed by 2246.4% in 2022, and later surged by 5430.21% in 2024.
  • Over the past 5 years, Amgen's Operating Expenses (Quarter) stood at $4.5 billion in 2021, then grew by 1.48% to $4.6 billion in 2022, then skyrocketed by 50.25% to $6.9 billion in 2023, then dropped by 2.17% to $6.8 billion in 2024, then grew by 3.78% to $7.0 billion in 2025.
  • Its last three reported values are $7.0 billion in Q3 2025, $6.5 billion for Q2 2025, and $7.0 billion during Q1 2025.